Cargando…

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers

Omiganan (OMN; a synthetic cationic peptide) and imiquimod (IMQ; a TLR7 agonist) have synergistic effects on interferon responses in vitro. The objective of this study was to translate this to a human model for proof‐of‐concept, and to explore the potential of OMN add‐on treatment for viral skin dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niemeyer‐van der Kolk, Tessa, Assil, Salma, Buters, Thomas P., Rijsbergen, Melanie, Klaassen, Erica S., Feiss, Gary, Florencia, Edwin, Prens, Errol P., Burggraaf, Jacobus, van Doorn, Martijn B.A., Rissmann, Robert, Moerland, Matthijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214655/ https://www.ncbi.nlm.nih.gov/pubmed/32043302 http://dx.doi.org/10.1111/cts.12741

Ejemplares similares

Comprehensive, Multimodal Characterization of an Imiquimod‐Induced Human Skin Inflammation Model for Drug Development
por: van der Kolk, Tessa, et al.
Publicado: (2018)

Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model
por: Assil, Salma, et al.
Publicado: (2023)

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial
por: Niemeyer‐van der Kolk, Tessa, et al.
Publicado: (2020)

Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial
por: Rousel, Jannik, et al.
Publicado: (2023)

Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells
por: Grievink, Hendrika W., et al.
Publicado: (2020)

A randomized controlled proof‐of‐concept trial of digoxin and furosemide in adults with cutaneous warts
por: Rijsbergen, M., et al.
Publicado: (2019)

A randomized controlled trial with a delayed‐type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man
por: Saghari, Mahdi, et al.
Publicado: (2020)

Blueprint for mechanistic, data‐rich early phase clinical pharmacology studies in dermatology
por: Rissmann, Robert, et al.
Publicado: (2020)

Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers
por: Buters, Thomas P., et al.
Publicado: (2022)

Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis
por: VAN DEN MUNCKHOF, Ellen H. A., et al.
Publicado: (2020)

Stereophotogrammetric three‐dimensional photography is an accurate and precise planimetric method for the clinical visualization and quantification of human papilloma virus‐induced skin lesions
por: Rijsbergen, M., et al.
Publicado: (2019)

Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
por: Rijsbergen, M., et al.
Publicado: (2019)

Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers
por: Buters, Thomas P., et al.
Publicado: (2021)

OX40L Inhibition Suppresses KLH‐driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof‐of‐Pharmacology for KY1005
por: Saghari, Mahdi, et al.
Publicado: (2022)

Remarkable Pharmacokinetics of Monoclonal Antibodies: A Quest for an Explanation
por: Reijers, Joannes A. A., et al.
Publicado: (2016)

Anticandidal Activity of Omiganan and Its Retro Analog Alone and in Combination with Fluconazole
por: Czechowicz, Paulina, et al.
Publicado: (2021)

Complement Activation in Inflammatory Skin Diseases
por: Giang, Jenny, et al.
Publicado: (2018)

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
por: Radanovic, Igor, et al.
Publicado: (2022)

Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts
por: van der Kolk, T., et al.
Publicado: (2017)

The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial
por: Grievink, Hendrika W., et al.
Publicado: (2020)

Novel SGLT2 inhibitor: first‐in‐man studies of antisense compound is associated with unexpected renal effects
por: van Meer, Leonie, et al.
Publicado: (2017)

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial
por: Wind, Selinde S., et al.
Publicado: (2022)

Under‐representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database
por: Ruiter, Rikje, et al.
Publicado: (2019)

Potential Influence of Endothelial Adsorption on the Delayed Time to Maximum Concentration of Biopharmaceuticals
por: Reijers, Joannes A. A., et al.
Publicado: (2017)

The Antimicrobial Activity of Omiganan Alone and In Combination against Candida Isolated from Vulvovaginal Candidiasis and Bloodstream Infections
por: Żyrek, Dawid, et al.
Publicado: (2021)

Clinical Evaluation of Humira(®) Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
por: Dillingh, Marlous R., et al.
Publicado: (2016)

A systematic literature review of the human skin microbiome as biomarker for dermatological drug development
por: Niemeyer ‐ van der Kolk, T., et al.
Publicado: (2018)

Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510
por: Wind, Selinde S., et al.
Publicado: (2023)

Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals
por: Reijers, Joannes A. A., et al.
Publicado: (2019)

Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey
por: Bik, Liora, et al.
Publicado: (2023)

Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using Ex Vivo T Cell Function Assays
por: in ’t Veld, Aliede E., et al.
Publicado: (2023)

Monitoring of Ex Vivo Cyclosporin a Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics
por: in ’t Veld, Aliede E., et al.
Publicado: (2022)

Gender differences in clinical registration trials: is there a real problem?
por: Labots, Geert, et al.
Publicado: (2018)

Efficacy and safety of needle-free jet injector-assisted intralesional treatments in dermatology—a systematic review
por: Bekkers, Vazula Zulfra, et al.
Publicado: (2023)

Whole blood assay as a model for in vitro evaluation of inflammasome activation and subsequent caspase-mediated interleukin-1 beta release
por: Tran, Thi Anh Thu, et al.
Publicado: (2019)

Needle‐free jet injection‐induced small‐droplet aerosol formation during intralesional bleomycin therapy
por: Bik, Liora, et al.
Publicado: (2021)

Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a ((26)Al)Al microtracer approach: a follow-up study in humans
por: de Ligt, Rianne, et al.
Publicado: (2022)

The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases
por: Jacobse, Justin, et al.
Publicado: (2018)

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?
por: in ‘t Veld, Aliede E., et al.
Publicado: (2019)

Impact of oral administration of single strain Lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteers
por: Saghari, Mahdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_24d302d6rgnrjvbo10k81es4tu